Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid injection comparison for trigger finger
NL-OMON54114Phase 4Completed
- Sponsor
- Jeroen Bosch Hospital
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triamcinolone and methylprednisolone in trigger finger and stenosing tenosynovitis (3 arms), sponsored by Jeroen Bosch Hospital. Primary endpoints: Primary treatment success rate, Number of injections needed and 1 more. Started Jun 2020; status: completed.
02
Drugs
triamcinolonemethylprednisolone
03
Conditions
trigger fingerstenosing tenosynovitis
Beyond the preview
Go deeper on NL-OMON54114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54114.